Welcome to our dedicated page for American Express Co SEC filings (Ticker: AXP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
American Express Company (NYSE: AXP) files a range of reports with the U.S. Securities and Exchange Commission that provide detailed information about its operations, credit performance and capital markets activity. As a New York–incorporated financial services company, American Express reports under Commission File Number 1-7657 and discloses its principal executive office in New York in its current reports.
On this SEC filings page, users can access American Express current reports on Form 8-K, which have recently included monthly delinquency and net write-off statistics for U.S. consumer and U.S. small business card member loans held for investment. These filings present data on total loans, delinquency percentages and net write-off rates based on principal only, as well as performance metrics for the American Express Credit Account Master Trust. The company explains that trust-level performance can differ from overall portfolio performance due to differences in mix, vintage, aging and calculation methods.
American Express also uses Form 8-K to report other events, such as the issuance of fixed-to-floating rate notes and floating rate notes under its shelf registration statement, and to furnish earnings releases and additional financial information for specific quarters. Certain filings discuss leadership changes and other corporate developments.
Through Stock Titan, these filings are available with AI-powered summaries that highlight key points from lengthy documents, helping users quickly understand items such as credit trends, new debt issuances and notable corporate events. Investors interested in AXP can review annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and, where applicable, insider transaction reports on Form 4 to gain a more complete view of American Express’s regulatory disclosures and governance.
American Express (AXP) reported an insider equity award. The company’s Group President, GMNS, reported 67,365 employee stock options with an exercise price of $148.45 from a performance-based grant originally made in October 2022.
The options are first exercisable on 10/31/2026 and expire on 10/31/2029. According to the filing, 75% of the award has vested based on performance criteria, while the remaining 25% is contingent on meeting performance goals and continued employment through 10/31/2026.
American Express (AXP) reported an insider equity award by its Group President, Global Consumer Services. On 10/31/2025, the officer acquired 67,365 employee stock options at an exercise price of $148.45 per share, recorded as Direct ownership.
The options are listed as exercisable beginning 10/31/2026 and expiring on 10/31/2029, with a post-transaction balance of 67,365 derivative securities. According to the note, the award was granted in October 2022 and is tied to performance: 75% has vested, while the remaining 25% depends on meeting performance criteria and continued employment through October 31, 2026.
American Express (AXP) reported an insider equity award. A company officer acquired 52,395 employee stock options on 10/31/2025 at a $148.45 exercise price, coded A(1). The options are first exercisable on 10/31/2026 and expire on 10/31/2029, with 52,395 derivative securities beneficially owned directly after the transaction.
According to the footnote, these options relate to a performance stock option grant from October 2022, of which 75% has vested based on performance criteria. The remaining 25% depends on meeting performance criteria and continued employment through October 31, 2026.
American Express (AXP) reported an insider equity transaction by its Group President, U.S. Consumer Services. On 10/31/2025, the officer acquired 52,395 employee stock options at an exercise price of $148.45. These options become exercisable on 10/31/2026 and expire on 10/31/2029.
The filing notes that the award stems from performance stock options granted in October 2022, of which 75% have vested based on specified performance criteria. The remaining 25% depend on meeting performance conditions and continued employment through October 31, 2026.
American Express (AXP) — Form 144 notice: A holder filed to sell 50,000 shares of common stock, with an aggregate market value of $17,944,000. The shares were acquired on 10/31/2025 via cash exercise of stock options from the issuer, and the planned sale date is 10/31/2025.
The proposed sales are to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services on the NYSE. This filing is a notice of potential sales under Rule 144 and does not represent a company offering. The table lists 688,851,653 shares outstanding.
American Express submitted a Form 13F disclosing institutional holdings. The report lists 2 holdings with a combined reported market value of $1,275,236,260. The filing was signed by James J. Killerlane III on 10-31-2025.
American Express (AXP) reported an insider transaction by its Chief Risk Officer. On 10/23/2025, the officer sold 2,515 shares of common stock at $355.61 per share (transaction code S, disposition). The filing also lists 103.15 shares held indirectly through the company’s Retirement Savings Plan, which uses unit accounting that can change the deemed share count.
American Express (AXP) insider transaction: An officer identified as Pres., Enterprise Shared Serv. reported a sale of common stock. On 10/22/2025, the reporting person sold 5,000 shares at a price of $350.73 per share.
Following the sale, the filing shows 7,725.739 shares beneficially owned directly. In addition, 1,797 shares are held indirectly by the reporting person through the Company’s Employee Stock Ownership Plan. Notes indicate some shares were acquired via dividend reinvestment.
American Express Company reported the issuance of $2,000,000,000 aggregate principal amount of 4.804% Fixed-to-Floating Rate Notes due October 24, 2036. The notes were issued on October 24, 2025 under the company’s shelf registration, pursuant to a Prospectus Supplement dated October 20, 2025 to a Prospectus dated February 9, 2024.
The Notes were issued under the senior indenture dated August 1, 2007, as supplemented on February 12, 2021 and May 1, 2023, with The Bank of New York Mellon serving as trustee. This filing also includes related legal opinions and consents as exhibits.
AXP: A Form 144 notice discloses a proposed sale of 2,515 shares of common stock with an aggregate market value of $894,359.15. The filing lists Morgan Stanley Smith Barney LLC as broker, with an approximate sale date of 10/23/2025 on the NYSE.
The shares were acquired on 01/28/2025 through restricted stock vesting under a registered plan. Shares outstanding were 688,851,653; this is a baseline figure, not the amount being offered.